1 |
(s)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazo |
- |
- |
- |
- |
284 [1] 284 💬 |
2 |
(s)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide |
Hydroxide ion |
[1] D00731 D00731 💬 |
- |
- |
284 [1] 284 💬 |
3 |
(s)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-m |
- |
- |
- |
- |
284 [1] 284 💬 |
4 |
(s)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide |
Hydroxide ion |
[1] D00731 D00731 💬 |
- |
- |
284 [1] 284 💬 |
5 |
Abatacept |
Abatacept |
[1] D03203 D03203 💬 |
CD80 [2] CD80, CD86 💬 |
Allograft rejection [12] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
6 |
Alefacept |
Alefacept |
[1] D02800 D02800 💬 |
CD58 [1] CD58 💬 |
Cell adhesion molecules [2] Cell adhesion molecules, Epstein-Barr virus infection |
037 [6] 37, 60, 65, 164, 284, 285 💬 |
7 |
Alemtuzumab |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [16] 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
8 |
Alpha beta depletion |
- |
- |
- |
- |
060 [2] 60, 284 💬 |
9 |
Anti-thymocyte globulin |
- |
- |
- |
- |
011 [18] 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬 |
10 |
Antithymocyte globulin |
- |
- |
- |
- |
060 [3] 60, 65, 284 💬 |
11 |
Bpx-501 t cells |
- |
- |
- |
- |
065 [4] 65, 284, 285, 326 💬 |
12 |
Busulfan |
Busulfan |
[1] D00248 D00248 💬 |
- |
- |
019 [13] 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬 |
13 |
Busulfan, cyclophosphamide, atg, gcsf |
Busulfan |
[3] D00248 D00248, D00287 D00287, D07760 D07760 💬 |
- |
- |
065 [2] 65, 284 💬 |
14 |
Busulfan, fludarabine, atg, tli |
Busulfan |
[3] D00248 D00248, D01907 D01907, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
065 [2] 65, 284 💬 |
15 |
Campath, fludarabine, cyclophosphamide |
Cyclophosphamide |
[4] D00287 D00287, D01907 D01907, D07760 D07760, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
065 [2] 65, 284 💬 |
16 |
Cd3/cd19 depleted leukocytes |
- |
- |
- |
- |
284 [1] 284 💬 |
17 |
Cd34 stem cell selection therapy |
- |
- |
- |
- |
060 [3] 60, 65, 284 💬 |
18 |
Cd45ra depleted leukocytes |
- |
- |
- |
- |
284 [1] 284 💬 |
19 |
Cyclophosphamide |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
011 [44] 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
20 |
Cyclophosphamide dose level 1 |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
065 [2] 65, 284 💬 |
21 |
Cyclophosphamide dose level 2 |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
065 [2] 65, 284 💬 |
22 |
Cyclophosphamide dose level 3 |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
065 [2] 65, 284 💬 |
23 |
Cyclophosphamide dose level 4 |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
065 [2] 65, 284 💬 |
24 |
Cyclosporine |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 [35] 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
25 |
Daclizumab |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [7] 13, 56, 60, 65, 97, 283, 284 💬 |
26 |
Deferasirox |
Deferasirox |
[1] D03669 D03669 💬 |
- |
- |
254 [3] 254, 284, 286 💬 |
27 |
Deferitazole |
Deferitazole |
[1] D10388 D10388 💬 |
- |
- |
284 [1] 284 💬 |
28 |
Deferoxamine |
Deferoxamine |
[2] D01186 D01186, D03670 D03670 💬 |
- |
- |
284 [2] 284, 286 💬 |
29 |
Desferal |
- |
- |
- |
- |
284 [2] 284, 286 💬 |
30 |
Dfo |
- |
- |
- |
- |
046 [3] 46, 284, 286 💬 |
31 |
Eltrombopag |
Eltrombopag |
[1] D03978 D03978 💬 |
- |
- |
060 [5] 60, 63, 65, 284, 285 💬 |
32 |
Enriched hematopoetic stem cell infusion |
- |
- |
- |
- |
013 [3] 13, 19, 284 💬 |
33 |
Exjade |
- |
- |
- |
- |
254 [3] 254, 284, 286 💬 |
34 |
Fbs0701 |
- |
- |
- |
- |
284 [1] 284 💬 |
35 |
Fbs0701 capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
36 |
Fbs0701/ssp004184 |
- |
- |
- |
- |
284 [1] 284 💬 |
37 |
Filgrastim |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [27] 2 , 6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
38 |
Fludarabine |
Fludarabine |
[2] D01907 D01907, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [17] 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 💬 |
39 |
Fludarabine monophosphate |
Fludarabine |
[2] D01907 D01907, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
065 [3] 65, 284, 326 💬 |
40 |
Fludarabine phosphate |
Fludarabine |
[2] D01907 D01907, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
028 [11] 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285 💬 |
41 |
G-csf |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [16] 2 , 6 , 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬 |
42 |
Human placental derived stem cell |
- |
- |
- |
- |
019 [4] 19, 20, 60, 284 💬 |
43 |
Hydroxide |
Hydroxide ion |
- |
- |
- |
046 [4] 46, 96, 97, 284 💬 |
44 |
Hydroxyurea |
Hydroxyurea |
[1] D00341 D00341 💬 |
RRM2 [1] RRM2 💬 |
Drug metabolism - other enzymes [6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway |
003 [8] 3 , 13, 19, 20, 65, 85, 86, 284 💬 |
45 |
Icl670 |
- |
- |
- |
- |
060 [3] 60, 284, 286 💬 |
46 |
Iron |
Iron |
- |
- |
- |
018 [5] 18, 96, 97, 254, 284 💬 |
47 |
Iron chelating agents |
- |
- |
- |
- |
284 [1] 284 💬 |
48 |
L-leucine |
Leucine |
[1] D00030 D00030 💬 |
- |
- |
284 [1] 284 💬 |
49 |
Lenalidomide |
Lenalidomide |
[1] D04687 D04687 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
016 [7] 16, 26, 28, 34, 49, 284, 300 💬 |
50 |
Leucine |
Leucine |
[1] D00030 D00030 💬 |
- |
- |
005 [10] 5 , 6 , 7 , 19, 96, 97, 127, 283, 284, 299 💬 |
51 |
Magnesium |
Magnesium |
- |
- |
- |
006 [16] 6 , 11, 13, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬 |
52 |
Magnesium hydroxide |
Hydroxide ion |
[1] D00731 D00731 💬 |
- |
- |
284 [1] 284 💬 |
53 |
Melphalan |
Melphalan |
[1] D00369 D00369 💬 |
- |
- |
011 [15] 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬 |
54 |
Mesenchymal stromal cells |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
002 [9] 2 , 36, 49, 51, 60, 96, 97, 274, 284 💬 |
55 |
Methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 [35] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
56 |
Methylprednisolone |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [44] 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
57 |
Mycophenolate |
Mycophenolic acid |
[1] D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 [34] 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
58 |
Mycophenolate mofetil |
Mycophenolate mofetil |
[4] D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 [32] 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
59 |
Myeloablative preparative regimen |
- |
- |
- |
- |
062 [3] 62, 65, 284 💬 |
60 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 [21] 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
61 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 [30] 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
62 |
Prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [47] 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
63 |
Procedure: allogeneic bone marrow transplantation |
- |
- |
- |
- |
060 [6] 60, 65, 96, 164, 284, 285 💬 |
64 |
Procedure: allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
028 [8] 28, 51, 60, 62, 65, 164, 284, 285 💬 |
65 |
Procedure: bone marrow transplantation |
- |
- |
- |
- |
051 [4] 51, 60, 284, 285 💬 |
66 |
Procedure: leukapheresis |
- |
- |
- |
- |
049 [5] 49, 51, 96, 284, 285 💬 |
67 |
Procedure: peripheral blood stem cell transplantation |
- |
- |
- |
- |
011 [11] 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285 💬 |
68 |
Procedure: radiation therapy |
- |
- |
- |
- |
013 [3] 13, 284, 285 💬 |
69 |
Procedure: stem cell infusion |
- |
- |
- |
- |
028 [5] 28, 60, 65, 284, 285 💬 |
70 |
Procedure: stem cell transplant |
- |
- |
- |
- |
019 [5] 19, 20, 65, 164, 284 💬 |
71 |
Procedure: total lymphoid irradiation |
- |
- |
- |
- |
065 [3] 65, 284, 326 💬 |
72 |
Procedure: umbilical cord blood transplantation |
- |
- |
- |
- |
060 [5] 60, 65, 284, 285, 326 💬 |
73 |
Radiation: radiation therapy |
- |
- |
- |
- |
034 [5] 34, 60, 65, 284, 285 💬 |
74 |
Radiation: total body irradiation |
- |
- |
- |
- |
036 [7] 36, 49, 51, 60, 65, 283, 284 💬 |
75 |
Radiation: total-body irradiation |
- |
- |
- |
- |
028 [9] 28, 51, 60, 62, 65, 96, 283, 284, 285 💬 |
76 |
Reduced intensity preparative regimen |
- |
- |
- |
- |
062 [3] 62, 65, 284 💬 |
77 |
Reduced toxicity ablative regimen |
- |
- |
- |
- |
062 [3] 62, 65, 284 💬 |
78 |
Rimiducid |
Rimiducid |
[1] D11195 D11195 💬 |
CASP9 [1] CASP9 💬 |
Alzheimer disease [34] Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway |
019 [6] 19, 60, 65, 284, 285, 326 💬 |
79 |
Rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
011 [47] 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
80 |
Rivogenlecleucel |
- |
- |
- |
- |
019 [6] 19, 60, 65, 284, 285, 326 💬 |
81 |
Sotatercept |
Sotatercept |
[1] D09670 D09670 💬 |
ACVR2A [1] ACVR2A 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway |
086 [2] 86, 284 💬 |
82 |
Sotatercept with prednisone boost |
Prednisone |
[2] D00473 D00473, D09670 D09670 💬 |
ACVR2A [2] ACVR2A, NR3C1 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Neuroactive ligand-receptor interaction, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway |
284 [1] 284 💬 |
83 |
Ssp-004184 100 mg |
- |
- |
- |
- |
284 [1] 284 💬 |
84 |
Ssp-004184 100 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
85 |
Ssp-004184 250 mg |
- |
- |
- |
- |
284 [1] 284 💬 |
86 |
Ssp-004184 250 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
87 |
Ssp-004184 375 mg |
- |
- |
- |
- |
284 [1] 284 💬 |
88 |
Ssp-004184 375 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
89 |
Ssp-004184 50 mg |
- |
- |
- |
- |
284 [1] 284 💬 |
90 |
Ssp-004184 50 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
91 |
Ssp-004184 500 mg |
- |
- |
- |
- |
284 [1] 284 💬 |
92 |
Ssp-004184 500 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
93 |
Ssp-004184aq 100 mg |
- |
- |
- |
- |
284 [1] 284 💬 |
94 |
Ssp-004184aq 100 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
95 |
Ssp-004184aq 200 mg |
- |
- |
- |
- |
284 [1] 284 💬 |
96 |
Ssp-004184aq 200 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
97 |
Ssp-004184aq 250 mg |
- |
- |
- |
- |
284 [1] 284 💬 |
98 |
Ssp-004184aq 250 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
99 |
Ssp-004184aq 375 mg |
- |
- |
- |
- |
284 [1] 284 💬 |
100 |
Ssp-004184aq 375 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
101 |
Ssp-004184aq 50 mg |
- |
- |
- |
- |
284 [1] 284 💬 |
102 |
Ssp-004184aq 50 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
103 |
Tacrolimus |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 [32] 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
104 |
Thiotepa |
Thiotepa |
[1] D00583 D00583 💬 |
- |
- |
013 [11] 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284 💬 |
105 |
Thiotepa--escalated dose |
Thiotepa |
[1] D00583 D00583 💬 |
- |
- |
019 [4] 19, 20, 65, 284 💬 |
106 |
Thiotepa--single daily dose |
Thiotepa |
[1] D00583 D00583 💬 |
- |
- |
019 [4] 19, 20, 65, 284 💬 |
107 |
Trifluoperazine |
Trifluoperazine |
[3] D00799 D00799, D01448 D01448, D08636 D08636 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
283 [2] 283, 284 💬 |